Gastric PD-L1
Gastric Cancer
CommercialActive
Key Facts
About Mindpeak
Mindpeak is a Hamburg-based AI/ML company operating at the intersection of digital pathology and precision medicine. It has developed a suite of CE-marked, deep learning-based software products that automate the analysis of immunohistochemistry (IHC) and H&E-stained tissue samples, primarily for oncology biomarkers like PD-L1, HER2, and Ki-67. The company's value proposition centers on '0-click' integration, offering both standalone and deeply embedded solutions within partner laboratory information systems to improve pathologist efficiency and diagnostic consistency. Mindpeak appears to be in a commercial, revenue-generating stage, serving diagnostic labs, hospitals, and research institutions.
View full company profileTherapeutic Areas
Other Gastric Cancer Drugs
| Drug | Company | Phase |
|---|---|---|
| inPROBE for HER2 | SDS Optic | Preclinical/Clinical Data Review |
| Venadaparib (IDX-1197) | Idience | Phase 1b/2a |
| VNX-203 | Vironexis Biotherapeutics | Preclinical |
| Gastric Cancer Biomarkers | Paradise Genomics | Discovery |
| TTFields | Novocure | Pilot |